Reliance Life Sciences Pvt. Ltd
| Scheme | Held | % of scheme | Sep 2026 |
|---|---|---|---|
| Axis Short Term Fund Axis Mutual Fund | ₹74.4 cr | 1.01% | ₹74.7 cr |
| ADITYA BIRLA SUN LIFE CORPORATE BOND FUND Aditya Birla Sun Life Mutual Fund | ₹49.6 cr | 0.21% | ₹49.8 cr |
| ADITYA BIRLA SUN LIFE FLOATING INTEREST RATES FUND Aditya Birla Sun Life Mutual Fund | ₹49.6 cr | 0.38% | ₹49.8 cr |
| Axis Ultra Short to Short Term Fund Axis Mutual Fund | ₹24.8 cr | 0.51% | ₹24.9 cr |
% of scheme: the share of the scheme's net assets, as the fund house states it. Sep 2026: "—" = no Sep 2026 portfolio from that fund house.
| Security | Grade or sector, as printed | Held | Schemes |
|---|---|---|---|
| 7.80% Reliance Life Sciences Pvt. Ltd. (05/11/2027) ** Bond / debenture · INE11LM07031 | CARE AAA | ₹198 cr | 4 |
Name, and the credit agency grade (or a sector, where the fund house prints one), as the fund houses print them: several spellings, the most common; several grades, all of them, most common first. This site gives no view on credit.
| Month | Held | Schemes | Fund houses holding / covered |
|---|---|---|---|
| Oct 2026 | ₹198 cr | 4 | 2 / 38 |
| Sep 2026 | ₹199 cr | 4 | 2 / 38 |
| Aug 2026 | ₹200 cr | 4 | 2 / 37 |
| Jul 2026 | ₹200 cr | 4 | 2 / 39 |
| Jun 2026 | ₹200 cr | 4 | 2 / 38 |
| May 2026 | ₹199 cr | 4 | 2 / 39 |
| Apr 2026 | ₹400 cr | 6 | 2 / 39 |
| Mar 2026 | ₹400 cr | 6 | 2 / 39 |
| Feb 2026 | ₹401 cr | 6 | 2 / 42 |
| Jan 2026 | ₹401 cr | 6 | 2 / 41 |
| Dec 2025 | ₹402 cr | 6 | 2 / 41 |
| Nov 2025 | ₹404 cr | 6 | 2 / 40 |
| Oct 2025 | ₹504 cr | 6 | 2 / 38 |
| Sep 2025 | ₹504 cr | 6 | 2 / 33 |
A month with fewer fund houses covered is not comparable in full with one with more. Bonds, debentures, commercial paper, certificates of deposit, securitised debt and preference shares a company, bank or trust issued, as each fund house lists them in its monthly portfolio. Government securities, REIT/InvIT units and fund units are not included. Credit agency grades are copied as the fund house prints them; this site gives no view on credit. Not investment advice.